Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
167%
upside
4 price targets
|
0
%
|
|
|
|
166%
upside
4 price targets
|
0
%
|
|
|
|
155%
upside
3 price targets
|
0
%
|
|
|
54
Karyopharm Therapeutics
KPTI
$101M
|
153%
upside
3 price targets
|
0
%
|
|
|
148%
upside
3 price targets
|
0
%
|
|
|
|
148%
upside
3 price targets
|
0
%
|
|
|
|
146%
upside
3 price targets
|
0
%
|
|
|
|
145%
upside
5 price targets
|
0
%
|
|
|
|
144%
upside
4 price targets
|
0
%
|
|
|
|
137%
upside
3 price targets
|
0
%
|
|
|
61
Solid Biosciences
SLDB
$461M
|
136%
upside
3 price targets
|
0
%
|
|
|
135%
upside
5 price targets
|
0
%
|
|
|
|
131%
upside
4 price targets
|
0
%
|
|
|
|
130%
upside
6 price targets
|
0
%
|
|
|
|
128%
upside
3 price targets
|
0
%
|
|
|
|
127%
upside
4 price targets
|
0
%
|
|
|
|
125%
upside
6 price targets
|
0
%
|
|
|
|
123%
upside
3 price targets
|
0
%
|
|
|
|
122%
upside
5 price targets
|
0
%
|
|
|
|
122%
upside
4 price targets
|
0
%
|
|
|
|
121%
upside
4 price targets
|
0
%
|
|
|
|
118%
upside
3 price targets
|
0
%
|
|
|
|
114%
upside
6 price targets
|
0
%
|
|
|
|
113%
upside
3 price targets
|
0
%
|
|
|
|
113%
upside
4 price targets
|
0
%
|
|